P42330 (AK1C3_HUMAN) Homo sapiens (Human)

Aldo-keto reductase family 1 member C3 UniProtKBInterProSTRINGInteractive Modelling

323 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

60 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal Structure of AKR1C3 complexed with octyl gallatehomo-2-mer6-320
100NAP;65D;
Crystal Structure of AKR1C3 complexed with CAPEhomo-2-mer6-320
100NAP;QAP;
Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety…homo-2-mer6-319
100NAP;CJ2;
Crystal structure of human 17bet a-hydroxysteroid dehydrogenase type 5 in complexes with PEG and NA…monomer1-323
99.68ACT;P6G;NAP;
Prostaglandin F synthase complexed with NADPH and rutinmonomer5-323
99.69NDP;RUT;
Structure of prostaglandin F synthase with prostaglandin D2monomer5-323
99.69NAP;PG2;
Crystal structures of AKR1C3 binary complex with NADP+monomer5-323
100NAP;EDO;ACT;
Crystal structure of Aldo-keto reductase 1C3 complexed with compound S07044monomer2-320
100NAP;8FO;
Crystal structure of prostaglandin F synathase containing bimatoprostmonomer5-323
99.69NAP;15M;
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) complexed with delta…monomer5-323
99.68ACT;NAP;ASD;
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihyd…monomer5-323
100.0NAP;0T0;EDO;
Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety…monomer6-323
100CVN;CL;NAP;
Crystal structure of Aldo-Keto Reductase 1C3 (AKR1C3) complexed with inhibitor.monomer6-323
100NAP;FFW;EDO;
W227F active site mutant of AKR1C3monomer4-321
99.67NAP;EDO;ACT;PG4;
STRUCTURE OF ALDO-KETO REDUCTASE 1C3 (AKR1C3) IN COMPLEX WITH AN INHIBITOR MEDS765monomer6-323
100NAP;A1ICG;EDO;MES;
Structure of Aldo-Keto Reductase 1C3 (AKR1C3) in complex with an inhibitor M689, with the 3-hydroxy…monomer6-323
100.0NAP;YMC;EDO;
AKR1C3 complexed with new inhibitor with novel scaffoldmonomer6-323
100NAP;9S0;DMF;
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (4-(4-Chlorop…monomer6-323
100.0NAP;16J;EDO;
Crystal structure of human androgenic 17beta-hydroxysteroid dehydrogenase type 5 in complexed with …monomer5-321
99.68ACT;E04;NAP;
AKR1C3 complexed with 3-phenoxybenzoic acidmonomer6-322
100.0NAP;VJJ;EDO;
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 1-{4-[(2-meth…monomer5-321
100.0NAP;10H;
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (R)-1-(naphth…monomer6-322
100.0NAP;0SL;EDO;ACT;
AKR1C3 complex with naproxenmonomer6-322
100.0NAP;NPS;EDO;
AKR1C3 complexed with breakdown product of N-(tert-butyl)-2-(2-chloro-4-(((3-mercapto-5-methyl-4H-1…monomer6-321
100NAP;YY2;YY1;EDO;
AKR1C3 complex with indomethacin at pH 7.5monomer6-321
100.0NAP;IMN;EDO;
AKR1C3 complex with ibuprofenmonomer6-321
100.0NAP;IZP;EDO;
Crystal structures of AKR1C3 ternary complex with NADP+ and the chromene derivative 2lmonomer5-320
100NAP;FJU;
Crystal structures of AKR1C3 ternary complex with NADP+ and the chromene derivative 2jmonomer5-320
100NAP;FJR;
AKR1C3 complex with R-naproxenmonomer6-321
100.0NAP;NPX;EDO;
AKR1C3 complex with zomepiracmonomer6-321
100.0NAP;ZOM;EDO;
AKR1C3 complex with meclofenamic acidmonomer6-321
100.0NAP;JMS;EDO;
Crystal structures of prostaglandin D2 11-ketoreductase (AKR1C3) in complex with the non-steroidal …monomer6-321
100ACT;NAP;MPD;
AKR1C3 complexed with mefenamic acidmonomer6-321
100.0NAP;ID8;EDO;
AKR1C3 complex with flurbiprofenmonomer6-321
100.0NAP;FLR;EDO;
AKR1C3 complex with sulindacmonomer6-321
100.0NAP;SUZ;EDO;
Crystal structure of Aldo-keto reductase 1C3 complexed with compound S0703monomer5-320
100NAP;JTN;
17beta-HSD5 in complex with 4-nitro-2-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}methyl)phenolmonomer6-321
100.0NAP;WDV;
Crystal structures of prostaglandin D2 11-ketoreductase (AKR1C3) in complex with the non-steroidal …monomer6-320
100ACT;NAP;MPD;
17beta-HSD5 in complex with 2-nitro-5-(phenylsulfonyl)phenolmonomer6-320
100NAP;WDT;
17beta-HSD5 in complex with 3-pentyl-2-[(pyridin-2-ylmethyl)sulfanyl]-7-(pyrrolidin-1-ylcarbonyl)qu…monomer6-320
100NAP;WDS;
Crystal structures of prostaglandin D2 11-ketoreductase in complex with the non-steroidal anti-infl…monomer6-320
100NAP;IMN;DMS;UNX;
17beta-HSD5 in complex with 4-chloro-N-(4-chlorobenzyl)-5-nitro-1H-pyrazole-3-carboxamidemonomer6-320
100NAP;WDU;
Crystal structures of prostaglandin D2 11-ketoreductase in complex with the non-steroidal anti-infl…monomer6-320
100NAP;FLF;DMS;
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP…monomer6-320
100NAP;511;
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP…monomer6-320
100NAP;0HV;
Crystal structure of AKR1C3 complexed with glicazidemonomer6-320
100NAP;GCZ;
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihyd…monomer6-320
100NAP;0SZ;EDO;
Crystal structure of Aldo-keto reductase 1C3 complexed with compound S07054monomer6-320
100.0NAP;8IT;
Crystal structure of AKR1C3 complexed with glibenclamidemonomer6-320
100NAP;GBM;
Crystal structure of AKR1C3 complexed with glimepiridemonomer6-320
100GMR;NAP;
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP…monomer6-320
100NAP;BT9;
Crystal structure of Aldo-keto reductase 1C3 complexed with compound S07045monomer6-320
100NAP;8IH;
Structure of AKR1C3 in complex with a bile acid fused tetrazole inhibitormonomer6-319
100NAP;QBO;NA;
AKR1C3 complex with indomethacin at pH 6.8monomer6-319
100.0NAP;IMN;DMS;EDO;
Crystal structure of AKR1C3 in complex with DFVmonomer6-319
100NAP;DFV;
Crystal structure of Aldo-keto reductase 1C3 complexed with compound 25monomer6-319
100NAP;4ZI;
Crystal structure of Aldo-keto reductase 1C3 complexed with compound 28monomer6-319
100NAP;4R6;
Crystal structure of Aldo-keto reductase 1C3 complexed with compound 24monomer6-319
100NAP;4IV;
17beta-HSD5 in complex with [4-(2-hydroxyethyl)piperidin-1-yl](5-methyl-1H-indol-2-yl)methanonemonomer6-311
100.0NAP;WDX;
17beta-HSD5 in complex with 3,6-dihydropyridin-1(2H)-yl(5-methyl-1H-indol-2-yl)methanonemonomer6-306
100.0NAP;WDW;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1ry8.1.Amonomer0.875-323
NDP;RUT;99.69

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26f78.1.Amonomer0.831-204
100.00